Diagnostic use of epitope detection in monocytes blood test for early detection of colon cancer metastasis

Future Oncology

Volumn 9, Issue 4, 2013, Pages 605-609

  Jansen, Natalie ^a   Coy, Johannes F ^b  

^a General Practitioner   (Germany)

^b Darmstadt and Tavargenix GmbH   (Germany)

Author keywords

Apo10; blood test; cancer; colon; diagnostic; epitope detection in monocytes; oncology; TKTL1; tumor marker

Indexed keywords

CA 19-9 ANTIGEN; CARCINOEMBRYONIC ANTIGEN; EPITOPE; HEMOGLOBIN;

AFTERCARE; AGED; ANEMIA; ARTICLE; BLOOD ANALYSIS; CANCER DIAGNOSIS; CANCER PALLIATIVE THERAPY; CASE REPORT; CLINICAL EFFECTIVENESS; COLON CARCINOMA; DIAGNOSTIC VALUE; EPITOPE DETECTION IN MONOCYTES; HUMAN; MALE; METASTASIS; MONOCYTE; NUCLEAR MAGNETIC RESONANCE IMAGING; OCCULT BLOOD TEST; PATIENT MONITORING; PRACTICE GUIDELINE; PRIORITY JOURNAL;

AGED; COLONIC NEOPLASMS; EARLY DETECTION OF CANCER; EPITOPES; HUMANS; MALE; MONOCYTES; TRANSKETOLASE; TUMOR MARKERS, BIOLOGICAL;

EID: 84875945114     PISSN: 14796694     EISSN: 17448301     Source Type: Journal    
DOI: 10.2217/fon.13.8     Document Type: Article

References (14)

1. Japink D, Leers MP, Sosef MN, Nap M. CEA in activated macrophages. New diagnostic possibilities for tumor markers in early colorectal cancer. Anticancer Res. 29, 3245-3251 (2009).
2. Arnholdt J. Therapy monitoring and early detection of metastasis using tumor protein detection in macrophages. Anticancer Res. 31, 1957-2016 (2011).
3. Rotmann AR, Hofmann HA, Coy JF. Apo10 - a new biomarker for early detection of disorders of cell proliferation and solid tumours. Presented at: XX FIGO World Congress of Gynecology & Obstetrics. Rome, Italy, 7-12 October 2012
4. Feyen O, Coy JF, Prasad V, et al. EDIM-TKTL1 blood test: a noninvasive method to detect upregulated glucose metabolism in patients with malignancies. Future Oncol. 8, 1349-1359 (2012).
5. Riganti C, Gazzano E, Polimeni M, et al. The pentose phosphate pathway: an anti-oxidant defense and a cross-road in tumor cell fate. Free Radic. Biol. Med. 53, 421-436 (2012).
6. Langbein S, Zerilli M, Zur Hausen A, et al. Expression of transketolase TKTL1 predicts colon and urothelial cancer patient survival: Warburg effect reinterpreted. Br. J. Cancer 94, 578-585 (2006). (Pubitemid 43289763)
7. Schwaab J, Horisberger K, Strobel P, et al. Expression of transketolase like gene 1 (TKTL1) predicts disease-free survival in patients with locally advanced rectal cancer receiving neoadjuvant chemoradiotherapy. Biomed. Cancer 11, 363 (2011).
8. Schmiegel W, Pox C, Reinacher-Schick A, et al. S3 guideline 'colorectal carcinoma'. Results from evidence based consensus conferences (Feb 2004 and June 2007). Z. Gastroenterol. 46, 1-73 (2008).
9. Jemal A, Bray F, Center MM, et al. Global cancer statistics. CA Cancer J. Clin. 61, 69-90 (2010).
10. WHO. Cancer. Fact Sheet No. 297. WHO, Geneva, Switzerland (2012).
11. Rodríguez-Moranta F, Saló J, Arcusa A, et al. Postoperative surveillance in patients with colorectal cancer who have undergone curative resection: a prospective, multicenter, randomized, controlled trial. J. Clin. Oncol. 24, 386-393 (2006) (Pubitemid 46630457)
12. Hara M, Kanemitsu Y, Hirai T, et al. Negative serum carcinoembryonic antigen has insufficient accuracy for excluding recurrence from patients with Dukes C colorectal cancer: analysis with likelihood ratio and posttest probability in a follow-up study. Dis. Colon. Rectum 51, 1675-1680 (2008).
13. Locker G, Hamilton S, Harris J, et al. ASCO 2006 update of recommendations for the use of tumor markers in gastrointestinal cancer. J. Clin. Oncol. 24, 5313-5327 (2006). (Pubitemid 46631379)
14. Wanka C, Steinbach JP, Rieger J. Tp53-induced glycolysis and apoptosis regulator (TIGAR) protects glioma cells from starvation-induced cell death by upregulating respiration and improving cellular redox homeostasis. J. Biol. Chem. 287, 33436-33446 (2012).